Literature DB >> 18556566

Triglyceride-rich lipoprotein-associated apolipoprotein C-III production is stimulated by plasma free fatty acids in humans.

Mirjana Pavlic1, René Valéro, Hélène Duez, Changting Xiao, Linda Szeto, Bruce W Patterson, Gary F Lewis.   

Abstract

OBJECTIVE: Insulin resistant states are associated with increased fatty acid flux to liver and intestine, which stimulates the production of triglyceride-rich lipoproteins (TRL). ApoC-III production and plasma and TRL concentrations are increased in insulin resistance and may contribute to the hypertriglyceridemia of these conditions. The mechanism underlying that increase is not known, but because apoC-III and VLDL production are closely linked we hypothesized that FFAs may stimulate TRL apoC-III production. METHODS AND
RESULTS: We used Intralipid/heparin (IH) to raise plasma FFA in 12 healthy men in the fed state, and stable isotopes to examine apoC-III metabolism. TRL apoC-III concentration was significantly higher in the IH study, and this increase was associated with higher production (PR) and fractional catabolic rate (FCR). The increase in production was greater than in FCR (90% versus 30%, respectively), accounting for the elevated concentration. Glycerol infusion had no effect on apoC-III concentration, PR, or FCR compared to saline, indicating that the effect was not attributable to glycerol released from intralipid.
CONCLUSIONS: These findings confirm that TRL apoC-III production is stimulated by an acute elevation of plasma FFAs, suggesting a novel regulatory pathway that may play a role in the overproduction of TRL apoC-III in insulin resistant states.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18556566      PMCID: PMC3750732          DOI: 10.1161/ATVBAHA.108.169383

Source DB:  PubMed          Journal:  Arterioscler Thromb Vasc Biol        ISSN: 1079-5642            Impact factor:   8.311


  41 in total

1.  Plasma kinetics of apoC-III and apoE in normolipidemic and hypertriglyceridemic subjects.

Authors:  R Batal; M Tremblay; P H Barrett; H Jacques; A Fredenrich; O Mamer; J Davignon; J S Cohn
Journal:  J Lipid Res       Date:  2000-05       Impact factor: 5.922

Review 2.  Apolipoproteins C-I and C-III as important modulators of lipoprotein metabolism.

Authors:  N S Shachter
Journal:  Curr Opin Lipidol       Date:  2001-06       Impact factor: 4.776

3.  Triglycerides, apo C3 and Lp B:C3 and cardiovascular risk in type II diabetes.

Authors:  N Gervaise; M A Garrigue; G Lasfargues; P Lecomte
Journal:  Diabetologia       Date:  2000-06       Impact factor: 10.122

Review 4.  Mechanisms of hepatic very low-density lipoprotein overproduction in insulin resistance.

Authors:  K Adeli; C Taghibiglou; S C Van Iderstine; G F Lewis
Journal:  Trends Cardiovasc Med       Date:  2001-07       Impact factor: 6.677

Review 5.  Transcriptional regulatory mechanisms of the human apolipoprotein genes in vitro and in vivo.

Authors:  V I Zannis; H Y Kan; A Kritis; E E Zanni; D Kardassis
Journal:  Curr Opin Lipidol       Date:  2001-04       Impact factor: 4.776

6.  Disordered fat storage and mobilization in the pathogenesis of insulin resistance and type 2 diabetes.

Authors:  Gary F Lewis; André Carpentier; Khosrow Adeli; Adria Giacca
Journal:  Endocr Rev       Date:  2002-04       Impact factor: 19.871

7.  Apolipoprotein C-III, a strong discriminant of coronary risk in men and a determinant of the metabolic syndrome in both genders.

Authors:  Altan Onat; Gülay Hergenç; Vedat Sansoy; Manfred Fobker; Köksal Ceyhan; Sadik Toprak; Gerd Assmann
Journal:  Atherosclerosis       Date:  2003-05       Impact factor: 5.162

8.  Apolipoprotein B-100 kinetics in visceral obesity: associations with plasma apolipoprotein C-III concentration.

Authors:  Dick C Chan; Gerald F Watts; Trevor G Redgrave; Trevor A Mori; P Hugh R Barrett
Journal:  Metabolism       Date:  2002-08       Impact factor: 8.694

9.  Apolipoprotein C-III, metabolic syndrome, and risk of coronary artery disease.

Authors:  Oliviero Olivieri; Antonella Bassi; Chiara Stranieri; Elisabetta Trabetti; Nicola Martinelli; Francesca Pizzolo; Domenico Girelli; Simonetta Friso; Pier Franco Pignatti; Roberto Corrocher
Journal:  J Lipid Res       Date:  2003-10-16       Impact factor: 5.922

Review 10.  The role and mode of action of apolipoproteins CIII and AV: synergistic actors in triglyceride metabolism?

Authors:  Ko Willems van Dijk; Patrick C N Rensen; Peter J Voshol; Louis M Havekes
Journal:  Curr Opin Lipidol       Date:  2004-06       Impact factor: 4.776

View more
  17 in total

Review 1.  How do elevated triglycerides and low HDL-cholesterol affect inflammation and atherothrombosis?

Authors:  Francine K Welty
Journal:  Curr Cardiol Rep       Date:  2013-09       Impact factor: 2.931

2.  Fish oil -- how does it reduce plasma triglycerides?

Authors:  Gregory C Shearer; Olga V Savinova; William S Harris
Journal:  Biochim Biophys Acta       Date:  2011-10-25

Review 3.  Targeting inflammation in metabolic syndrome.

Authors:  Francine K Welty; Abdulhamied Alfaddagh; Tarec K Elajami
Journal:  Transl Res       Date:  2015-07-03       Impact factor: 7.012

4.  Serum proteomic analysis of diet-induced steatohepatitis and metabolic syndrome in the Ossabaw miniature swine.

Authors:  Lauren N Bell; Lydia Lee; Romil Saxena; Kerry G Bemis; Mu Wang; Janice L Theodorakis; Raj Vuppalanchi; Mouhamad Alloosh; Michael Sturek; Naga Chalasani
Journal:  Am J Physiol Gastrointest Liver Physiol       Date:  2010-02-18       Impact factor: 4.052

5.  Insulin acutely inhibits intestinal lipoprotein secretion in humans in part by suppressing plasma free fatty acids.

Authors:  Mirjana Pavlic; Changting Xiao; Linda Szeto; Bruce W Patterson; Gary F Lewis
Journal:  Diabetes       Date:  2009-12-22       Impact factor: 9.461

6.  Expression of apolipoprotein C-III in McA-RH7777 cells enhances VLDL assembly and secretion under lipid-rich conditions.

Authors:  Meenakshi Sundaram; Shumei Zhong; Maroun Bou Khalil; Philip H Links; Yang Zhao; Jahangir Iqbal; M Mahmood Hussain; Robin J Parks; Yuwei Wang; Zemin Yao
Journal:  J Lipid Res       Date:  2010-01       Impact factor: 5.922

7.  Kinetic studies of the metabolism of rapidly exchangeable apolipoproteins may leave investigators and readers with exchangeable results.

Authors:  Henry N Ginsberg; Rajasekhar Ramakrishnan
Journal:  Arterioscler Thromb Vasc Biol       Date:  2008-10       Impact factor: 8.311

8.  Elevated Levels of Apolipoprotein CIII Increase the Risk of Postprandial Hypertriglyceridemia.

Authors:  Yunpeng Guan; Xiaoyu Hou; Peipei Tian; Luping Ren; Yong Tang; An Song; Jiajun Zhao; Ling Gao; Guangyao Song
Journal:  Front Endocrinol (Lausanne)       Date:  2021-04-23       Impact factor: 5.555

9.  World Congress on Insulin Resistance, Diabetes, and Cardiovascular Disease: part 3.

Authors:  Zachary T Bloomgarden
Journal:  Diabetes Care       Date:  2011-09       Impact factor: 19.112

10.  Lack of the Lysosomal Membrane Protein, GLMP, in Mice Results in Metabolic Dysregulation in Liver.

Authors:  Xiang Yi Kong; Eili Tranheim Kase; Anette Herskedal; Camilla Schjalm; Markus Damme; Cecilie Kasi Nesset; G Hege Thoresen; Arild C Rustan; Winnie Eskild
Journal:  PLoS One       Date:  2015-06-05       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.